Literature DB >> 15148583

[Palliative treatment for colorectal cancer].

D Flieger1, R Keller, W Fischbach.   

Abstract

Over 50,000 new cases of colorectal cancer are diagnosed in Germany every year. About half of these patients will be cured by surgery. The other reoccur or present primarily with advanced disease. Recently, the survival of patients with metastasized disease has been prolonged from about 6 months with best supportive care alone to more than 20 months with combination chemotherapy. Therefore, adequate palliation is reasonable. Irresectable liver metastasis can be treated by locally ablative procedures such as radiofrequency ablation (RFA) or laserinduced thermotherapy (LITT). In the individual case resection of lung or brain metastasis should be discussed. Practitioners have to deal with plenty of supportive opportunities e.g. analgesics, bisphosphonates, central acting drugs, nutrition but also with drug side effects. In centers different endoscopic or interventional radiologic procedures are offered. Considering the variety of therapeutic options, it is prudent to discuss individual treatment plans in an interdisciplinary "tumor board" and involve the practitioners in the decision making.

Entities:  

Mesh:

Year:  2004        PMID: 15148583     DOI: 10.1007/s00108-004-1215-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  [Therapeutic strategies in colorectal cancer].

Authors:  D Flieger; R Keller; W Fischbach
Journal:  Dtsch Med Wochenschr       Date:  2003-09-12       Impact factor: 0.628

Review 2.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

Review 3.  Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures.

Authors:  Erick Gamelin; Laurence Gamelin; Laura Bossi; Stefan Quasthoff
Journal:  Semin Oncol       Date:  2002-10       Impact factor: 4.929

4.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.

Authors:  P C Simmonds
Journal:  BMJ       Date:  2000-09-02

5.  Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.

Authors:  M Margaret Kemeny; Sudeshna Adak; Bruce Gray; John S Macdonald; Thomas Smith; Stuart Lipsitz; Elin R Sigurdson; Peter J O'Dwyer; Al B Benson
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

6.  Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group.

Authors:  B Glimelius; A Jakobsen; W Graf; A Berglund; C Gadeberg; P Hansen; M Kjaer; N Brunsgaard; E Sandberg; B Lindberg; H Sellström; T Lorentz; L Påhlman; B Gustavsson
Journal:  Eur J Cancer       Date:  1998-04       Impact factor: 9.162

Review 7.  Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jonathan J Deeks; Lesley A Smith; Matthew D Bradley
Journal:  BMJ       Date:  2002-09-21

Review 8.  Arterial chemotherapy in the management of colorectal cancer: an overview.

Authors:  Y Z Patt; G M Mavligit
Journal:  Semin Oncol       Date:  1991-10       Impact factor: 4.929

9.  Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

Authors:  P Rougier; E Van Cutsem; E Bajetta; N Niederle; K Possinger; R Labianca; M Navarro; R Morant; H Bleiberg; J Wils; L Awad; P Herait; C Jacques
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie.

Authors:  B Nordlinger; J C Vaillant; M Guiguet; P Balladur; F Paris; P Bachellier; D Jaeck
Journal:  J Clin Oncol       Date:  1994-07       Impact factor: 44.544

View more
  1 in total

1.  [Significance of palliative resection of gastrointestinal tumors].

Authors:  S Beller; P M Schlag
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.